148 related articles for article (PubMed ID: 34649939)
21. Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS.
LeBeau MA; Montgomery MA; Miller ML; Burmeister SG
J Anal Toxicol; 2000 Sep; 24(6):421-8. PubMed ID: 10999347
[TBL] [Abstract][Full Text] [Related]
22. An observed rise in γ-hydroxybutyrate-associated deaths in London: Evidence to suggest a possible link with concomitant rise in chemsex.
Hockenhull J; Murphy KG; Paterson S
Forensic Sci Int; 2017 Jan; 270():93-97. PubMed ID: 27936427
[TBL] [Abstract][Full Text] [Related]
23. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
Wood DM; Brailsford AD; Dargan PI
Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
[TBL] [Abstract][Full Text] [Related]
24. Psychosis in acute methamphetamine intoxication is usually self-limiting and can be managed in the emergency department: A retrospective series.
Humphreys M; Martin C; Theodoros T; Andronis D; Isoardi K
Emerg Med Australas; 2024 Feb; 36(1):24-30. PubMed ID: 37460167
[TBL] [Abstract][Full Text] [Related]
25. Effect of intubation for gamma-hydroxybutyric acid overdose on emergency department length of stay and hospital admission.
Dietze P; Horyniak D; Agius P; Munir V; Smit de V; Johnston J; Fry CL; Degenhardt L
Acad Emerg Med; 2014 Nov; 21(11):1226-31. PubMed ID: 25377399
[TBL] [Abstract][Full Text] [Related]
26. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
Dietze PM; Cvetkovski S; Barratt MJ; Clemens S
Med J Aust; 2008 Jun; 188(12):709-11. PubMed ID: 18558893
[TBL] [Abstract][Full Text] [Related]
27. What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')?
Wood DM; Button J; Ashraf T; Walker S; Greene SL; Drake N; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Mar; 101(3):207-13. PubMed ID: 18222986
[TBL] [Abstract][Full Text] [Related]
28. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
[TBL] [Abstract][Full Text] [Related]
29. Inpatient management of GHB/GBL withdrawal.
Delic M
Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
Towiwat P; Phattanarudee S; Maher TJ
Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
[TBL] [Abstract][Full Text] [Related]
31. Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity.
Wood DM; Greene SL; Dargan PI
Eur J Emerg Med; 2013 Aug; 20(4):263-7. PubMed ID: 22850087
[TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.
Baker LE; Van Tilburg TJ; Brandt AE; Poling A
Psychopharmacology (Berl); 2005 Sep; 181(3):458-66. PubMed ID: 16001124
[TBL] [Abstract][Full Text] [Related]
33. Patterns and features of methamphetamine-related presentations to emergency departments in QLD from 2005 to 2017.
Jones R; Woods C; Barker R; Usher K
Int J Ment Health Nurs; 2019 Aug; 28(4):833-844. PubMed ID: 31179592
[TBL] [Abstract][Full Text] [Related]
34. Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial.
Lingford-Hughes A; Patel Y; Bowden-Jones O; Crawford MJ; Dargan PI; Gordon F; Parrott S; Weaver T; Wood DM
Trials; 2016 Sep; 17(1):472. PubMed ID: 27677382
[TBL] [Abstract][Full Text] [Related]
35. Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors.
Corkery JM; Loi B; Claridge H; Goodair C; Schifano F
Curr Drug Metab; 2018; 19(13):1086-1099. PubMed ID: 29119924
[TBL] [Abstract][Full Text] [Related]
36. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
[TBL] [Abstract][Full Text] [Related]
37. High mortality rates among GHB abusers in Western Sweden.
Knudsen K; Greter J; Verdicchio M
Clin Toxicol (Phila); 2008 Mar; 46(3):187-92. PubMed ID: 18344100
[TBL] [Abstract][Full Text] [Related]
38. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony].
Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J
Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150
[TBL] [Abstract][Full Text] [Related]
39. Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency department.
Bunting PJ; Fulde GW; Forster SL
Med J Aust; 2007 Nov; 187(10):564-6. PubMed ID: 18021044
[TBL] [Abstract][Full Text] [Related]
40. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges.
Snead OC
Neuropharmacology; 1991 Feb; 30(2):161-7. PubMed ID: 2030821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
